Key result
Leadless pacemakers show no significant difference in complication risk versus transvenous pacemakers.
Why the study?
Leadless pacemakers were designed as an alternative to transvenous systems to avoid transvenous complications, but their pooled safety and efficacy required systematic review.
Does a leadless pacemaker reduce adverse events compared to a transvenous pacemaker in patients requiring single chamber ventricular pacing?
Meta-Analysis (n=2,496)
Does a leadless pacemaker reduce adverse events compared to a transvenous pacemaker in patients requiring single chamber ventricular pacing?
Relative Risk: 0.44 (95% CI 0.17–1.09)
Leadless pacemakers are safe and effective for single chamber ventricular pacing, with complication rates comparable to traditional transvenous pacemakers.
No takes yet. Share an insight, caveat, or question.
Supports the safety of leadless pacing as a viable alternative to transvenous systems; confirms.
Darlington et al. (2021) conducted a meta-analysis in Indication for single chamber ventricular pacing (n=2,496). Leadless pacemaker vs. Transvenous pacemaker was evaluated on Any complication (RR 0.44, 95% CI 0.17-1.09). Leadless pacemakers showed no significant difference in the risk of any complication compared to transvenous pacemakers (RR 0.44; 95% CI 0.17-1.09).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: